Hibiscus sabdariffa, a Treatment for Uncontrolled Hypertension. Pilot Comparative Intervention
2021
Al-Anbaki, Marwah | Cavin, Anne-Laure | Nogueira, Renata Campos | Taslimi, Jaafar | Ali, Hayder | Najem, Mohammed | Shukur Mahmood, Mustafa | Abdullah Khaleel, Ibrahim | Saad Mohammed, Abdulqader | Ramadhan Hasan, Hasan | Marcourt, Laurence | Félix, Fabien | Vinh Tri Low-Der’s, Nicolas | Ferreira Queiroz, Emerson | Wolfender, Jean-Luc | Watissée, Marie | Graz, Bertrand
In Iraq, in 2019, there were about 1.4 million Internally Displaced Persons (IDP); medical treatments were often interrupted. The feasibility of using Hibiscus sabdariffa (HS) decoction to curb hypertension was evaluated. A multicentric comparative pilot intervention for 121 participants with high blood pressure (BP) (≥140/90 mmHg) was conducted. Participants of the intervention group (with or without conventional medication) received HS decoction on a dose regimen starting from 10 grams per day. BP was measured five times over six weeks. The major active substances were chemically quantified. Results: After 6 weeks, 61.8% of participants from the intervention group (n = 76) reached the target BP < 140/90 mmHg, compared to 6.7% in the control group (n = 45). In the intervention group, a mean (±SD) reduction of 23.1 (±11.8) mmHg and 12.0 (±11.2) for systolic and diastolic BP, respectively, was observed, while in the control group the reduction was 4.4 (±10.2)/3.6 (±8.7). The chemical analysis of the starting dose indicated a content of 36 mg of total anthocyanins and 2.13 g of hibiscus acid. The study shows the feasibility of using HS decoction in IDP’s problematic framework, as hibiscus is a safe, local, affordable, and culturally accepted food product.
显示更多 [+] 显示较少 [-]